CCMI
MRNA icon

Creative Capital Management Investments’s Moderna MRNA Stock Holding History

Creative Capital Management Investments’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.87K Buy
+41
New +$2.12K ﹤0.01% 651

Other funds holding MRNA

BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
OIAM
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Creative Capital Management Investments's MRNA Position: Q2 2026 in Review

Creative Capital Management Investments opened a new position in Moderna (MRNA) in Q2 2026: 41 shares worth $2.87K. The stake represents ﹤0.01% of the portfolio and ranks #651 among its holdings.

184 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Creative Capital Management Investments held 41 shares of Moderna worth $2.87K as of Q2 2026.
  • Moderna was a new Creative Capital Management Investments position in Q2 2026.
  • Moderna made up ﹤0.01% of Creative Capital Management Investments's portfolio in Q2 2026, its #651 holding.
  • 184 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Creative Capital Management Investments's 13F filing for Q2 2026, filed 24 Jul 2026.